Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 11
(4)
◽
pp. 389-394
◽
2019 ◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 47
(2)
◽
pp. 182-188
◽
Keyword(s):
Keyword(s):